These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15560461)

  • 1. [Disease spectrum caused by atypical mycobacteria].
    Katila ML; Ruokonen EL; Eskola J; Lamberg MA
    Duodecim; 2004; 120(18):2240-6. PubMed ID: 15560461
    [No Abstract]   [Full Text] [Related]  

  • 2. [Atypical mycobacteria today].
    Schröder KH
    Offentl Gesundheitswes; 1983 Jan; 45(1):38-40. PubMed ID: 6219321
    [No Abstract]   [Full Text] [Related]  

  • 3. [Sensitivity of Mycobacterium intracellulare and Mycobacterium kansasii to antituberculous drugs].
    Zhao T; Yang SR
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1986 Dec; 9(6):359-60, 383. PubMed ID: 3582058
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antibacterial activity of Enviomycin for atypical mycobacteria. 2. Animal experiments (author's transl)].
    Toyohara M
    Kekkaku; 1979 Sep; 54(9):461-5. PubMed ID: 502153
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mycobacterial bases of the therapy of mycobacterioses].
    Hejný J
    Z Erkr Atmungsorgane; 1982; 158(1-2):163-7. PubMed ID: 7072265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The resistance of atypical mycobacteria to antitubercular preparations].
    Sybirnyĭ AV
    Mikrobiol Z; 1998; 60(2):75-9. PubMed ID: 9670757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disseminated infection caused by slow-growing Mycobacterium lentiflavum.
    Ibáñez R; Serrano-Heranz R; Jiménez-Palop M; Román C; Corteguera M; Jiménez S
    Eur J Clin Microbiol Infect Dis; 2002 Sep; 21(9):691-2. PubMed ID: 12373506
    [No Abstract]   [Full Text] [Related]  

  • 8. [Diseases caused by atypical mycobacteria--diagnosis and therapy].
    Franz H
    Offentl Gesundheitswes; 1987; 49(8-9):449-55. PubMed ID: 2958749
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antibacterial activity of enviomycin for atypical mycobacteria. 1. Antibacterial activity in vitro (author's transl)].
    Toyohara M
    Kekkaku; 1978 Apr; 53(4):255-60. PubMed ID: 661057
    [No Abstract]   [Full Text] [Related]  

  • 10. Usefulness of the Etest for studying tigecycline susceptibility of non-pigmented rapidly growing mycobacteria.
    Martín-de-Hijas NZ; Fernández-Roblas R; Fernandez-Martínez AI; Gadea I; Esteban J
    Int J Antimicrob Agents; 2008 Oct; 32(4):366-7. PubMed ID: 18572391
    [No Abstract]   [Full Text] [Related]  

  • 11. [Sensitivities of atypical mycobacteria to various drugs. V. Sensitivities of Mycobacterium intracellulare to some aminoglycoside and peptide antibiotics (author's transl)].
    Naito Y; Kuze F; Maekawa N
    Kekkaku; 1979 Aug; 54(8):423-7. PubMed ID: 537304
    [No Abstract]   [Full Text] [Related]  

  • 12. [Modern diagnostics of Mycobacterium tuberculosis].
    Eskola J; Soini H
    Duodecim; 2004; 120(18):2232-9. PubMed ID: 15560460
    [No Abstract]   [Full Text] [Related]  

  • 13. Tuberculostatic effect in vitro of certain new antibiotics (amikin, dalacin C, clindamycin, netromycin, tobramycin, lincomycin) on mycobacteria, particularly on M. avium.
    Sula L; Sulová J
    Czech Med; 1984; 7(2):122-8. PubMed ID: 6430657
    [No Abstract]   [Full Text] [Related]  

  • 14. The management of disease with atypical mycobacteria.
    Davidson PT
    Clin Notes Respir Dis; 1979; 18(1):3-13. PubMed ID: 477059
    [No Abstract]   [Full Text] [Related]  

  • 15. Nontuberculous mycobacterial infections of the skin: A retrospective study of 25 cases.
    Dodiuk-Gad R; Dyachenko P; Ziv M; Shani-Adir A; Oren Y; Mendelovici S; Shafer J; Chazan B; Raz R; Keness Y; Rozenman D
    J Am Acad Dermatol; 2007 Sep; 57(3):413-20. PubMed ID: 17368631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disseminated Mycobacterium peregrinum infection in a child with complete interferon-gamma receptor-1 deficiency.
    Koscielniak E; de Boer T; Dupuis S; Naumann L; Casanova JL; Ottenhoff TH
    Pediatr Infect Dis J; 2003 Apr; 22(4):378-80. PubMed ID: 12712974
    [No Abstract]   [Full Text] [Related]  

  • 17. [In vitro susceptibility of atypical mycobacteria to Cephem and other antibiotics].
    Sakurai N
    Kekkaku; 1983 Jun; 58(6):355-62. PubMed ID: 6620790
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecular genetic methods for diagnosis and antibiotic resistance detection of mycobacteria from clinical specimens.
    Shamputa IC; Rigouts And L; Portaels F
    APMIS; 2004; 112(11-12):728-52. PubMed ID: 15638836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pleurisy caused by Mycobacterium flavescens].
    de Escalante B; Lacasa J; Ruiz F; Sánchez E
    Enferm Infecc Microbiol Clin; 1994 Mar; 12(3):169. PubMed ID: 8011727
    [No Abstract]   [Full Text] [Related]  

  • 20. Recent clinical advances in knowledge of the nonleprous environmental mycobacteria responsible for cutaneous disease.
    Wallace RJ
    Arch Dermatol; 1987 Mar; 123(3):337-9. PubMed ID: 3813601
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.